Nasus Pharma Ltd (NSRX)

$8.05 -0.20 (-2.42%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -1.53M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 62,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
Latest News on NSRX
U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer

Aug 16, 2025, 12:25 AM EDT - 2 days ago

U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer

BLSH BUUU KLAR MAGH MIAX NUTR RYOJ

Nasus Pharma Announces Closing of Initial Public Offering

Aug 14, 2025, 4:05 PM EDT - 3 days ago

Nasus Pharma Announces Closing of Initial Public Offering

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

Aug 13, 2025, 7:30 AM EDT - 5 days ago

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

Nasus Pharma IPO Shows Promise But Risks Remain

Jul 16, 2025, 11:14 AM EDT - 4 weeks ago

Nasus Pharma IPO Shows Promise But Risks Remain

Israeli severe allergy biotech Nasus Pharma files and sets terms for an $11 million US IPO

Jul 9, 2025, 5:40 PM EDT - 5 weeks ago

Israeli severe allergy biotech Nasus Pharma files and sets terms for an $11 million US IPO

Nasus Pharma IPO Registration Document (F-1)

Jul 9, 2025, 3:59 PM EDT - 5 weeks ago

Nasus Pharma IPO Registration Document (F-1)